Home
> SARS-COV-2
SARS-COV-2
Dementia patients at higher risk of contracting COVID-19, hospitalisation
Some of the risk factors of dementia are genetics/family history, smoking, alcohol use, atherosclerosis, cholesterol, diabetes, and mild cognitive impairment.
Previous exposure to SARS virus may only offer limited protection against new coronavirus
An antibody, which was generated from a virus infection about 18 years ago from SARS, could only provide minimal defense against SARS-CoV-2.
Several gorillas test positive for COVID-19 in San Diego Zoo Safari Park
It was suspected that the gorillas contracted SARS-CoV-2 from an asymptomatic staff member at the safari park.
Coronavirus invades the brain and causes adverse effects, says study
When coronavirus enters the brain, the patient may experience brain fog and fatigue and can lead to cognitive issues.
Coronavirus mutations not proven to increase transmissibility in humans, study says
Researchers found that the human immune system was the one that mostly induced the mutation of the SARS-CoV-2 virus.
COVID-19: Experts attempt to predict spread of SARS-CoV-2 via smartphone location data
It will gather data from approximately 98 million Americans that reside in 10 major cities to analyse which areas are prone to another outbreak.
Coronavirus: UK reasearchers prepare for controversial human challenge trials
Given the urgency brought upon by the pandemic, government healthcare officials are pressured to deliver positive results.
Start-up medical drone delivery service receives backing from UK Space Agency
Similar to the ones that were introduced before it, the service will transport protective equipment, test kits, and samples to and from hospitals.
Covid-19: FDA approves Pfizer vaccine trials in teenagers and children as young as 12
The drugmaker confirmed that there are already parents interested to enroll their kids in the inoculation programme.
Coronavirus suppresses pain in early stages; people spread virus without knowing it
The SARS-CoV-2 virus may relieve pain, giving a possible explanation of why almost half of the people who get infected experience a few or no symptoms at all.
Regeneron seeks FDA emergency authorisation of Covid-19 antibody therapy used by Trump
Although REGN-COV2 is still currently in its trial phases, there have been exceptions allowed by the FDA such as the most recent one with Trump.
COVID-19 vaccine: Experts urge public not to expect dramatic changes
Even with the help of the United States' Operation Warp Speed initiative, it would likely take several months for doses to become accessible globally.
FDA proposal for stricter vaccine approval guidelines fail to get nod from White House
What the FDA suggested involves an extended period of observation of at least two months for trial participants.
COVID-19 anitbody treatment from Regeneron produces promising results in tests
Another observation that appears to bode well for folks who worry about the spread of SARS-CoV-2 is the reduction of viral load in the nasopharynx.
Google Maps latest update adds COVID-19 layer to show potential transmission hotspots
The feature is reportedly slated to go live within the week for Google Maps on both Android and iOS devices.
Coronavirus vaccine from Johnson & Johnson begins phase 3 trials; fourth in the US
The final phase of its trials will include up to 60,000 adult subjects and will be distributed across 215 sites in the U.S. as well as globally.
Coronavirus: CDC admits latest update was posted in error, takes down new guidelines
In July, around 239 scientists published an open letter addressed to the World Health Organization to warn people about the aerosols.
Experts suggest exposure to dengue may provide some immunity against coronavirus
The team found that areas with lower SARS-CoV-2 infection rates, were also the ones hard hit with the dengue fever outbreak either in 2019 or 2020.
The 90-minute COVID-19 test developed in the UK 'potential gamechanger': Scientists
Until now, the 2019 novel coronavirus tests accredited by regulators normally take at least 24 hours before results are published.
Sputnik V vaccine distribution draws criticism from experts over safety concerns
Russia is allegedly already entertaining purchase requests from low and middle-income countries who are hardest hit by SARS-CoV-2.
COVID-19 testing debacle in the UK draws harsh criticism from top lawmakers
Resources currently available were purportedly insufficient to handle the demand, which led to backlogs among several laboratories.
COVID-19: Long-term health issues after recovery continue to puzzle researchers
Post-hospitalisation COVID-19 study (PHOSP-COVID) is a UK-wide collaboration between leading researchers.
NHS COVID-19 contact tracing app to require businesses to put up QR code for users to scan
Establishments that normally see folks gather for more than 15 minutes will be asked to put up QR code posters designated by the government.
AstraZeneca virus vaccine final phase trials resume after setback: University of Oxford
Even though the delay might have surprised the public, those involved with the development of vaccines and drugs are familiar with instances such as this.
Covid-19 vaccine from Pfizer and BioNTech might face distribution issues
The formulation of the BNT162 jab from Pfizer needs to be stored at approximately 70 degrees Celsius below zero.
Cure ID app developed by FDA could potentially find best treatment for COVID-19
The Cure ID app was developed and launched by the United States Food and Drug Administration last year in December.
Walmart might soon deliver orders via drones as it explores other methods amid pandemic
The pilot programme for the retailer's new drone delivery system was launched on Wednesday and is currently limited to an area in North Carolina.
Second Russian COVID-19 vaccine candidate ends first two trial phases with positive results
Meanwhile, the BNT162 coronavirus vaccine candidates from Pfizer and BioNTech are eyeing regulatory approval by October.
Controversial Russian COVID-19 vaccine shows promising, safe results: Medical journal
The results of the Sputnik V vaccine experiments were published last week in the medical journal The Lancet.
Coronavirus vaccine candidates from GlaxoSmithKline, Sanofi begin clinical trials
As with other vaccine candidates, if the outcome of the first two phases is acceptable, the final phase might be scheduled before the end of 2020.